Cargando…
Therapeutic targets for HIV-1 infection in the host proteome
BACKGROUND: Despite the success of HAART, patients often stop treatment due to the inception of side effects. Furthermore, viral resistance often develops, making one or more of the drugs ineffective. Identification of novel targets for therapy that may not develop resistance is sorely needed. There...
Autores principales: | Liang, Winnie S, Maddukuri, Anil, Teslovich, Tanya M, de la Fuente, Cynthia, Agbottah, Emmanuel, Dadgar, Shabnam, Kehn, Kylene, Hautaniemi, Sampsa, Pumfery, Anne, Stephan, Dietrich A, Kashanchi, Fatah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087880/ https://www.ncbi.nlm.nih.gov/pubmed/15780141 http://dx.doi.org/10.1186/1742-4690-2-20 |
Ejemplares similares
-
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
por: Guendel, Irene, et al.
Publicado: (2010) -
The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells
por: Kehn, Kylene, et al.
Publicado: (2004) -
Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals
por: de la Fuente, Cynthia, et al.
Publicado: (2002) -
Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription
por: Agbottah, Emmanuel, et al.
Publicado: (2006) -
9-aminoacridine Inhibition of HIV-1 Tat Dependent Transcription
por: Guendel, Irene, et al.
Publicado: (2009)